Table 4.
Adverse outcomes and healthcare utilization among diabetic participants with different severities of frailty
| Variables | Number of events | Person-year | Incidence densitya | Crude HR | Modelb | Modelc | Modeld | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | ||||
| Mortality | |||||||||||
| Number of frailty components | |||||||||||
| 0 | 26,063 | 1521,110.06 | 17.13 | 1 | – | 1 | – | 1 | – | 1 | – |
| 1 | 13,435 | 363,900.81 | 36.92 | 2.16 | 2.11–2.2f | 1.05 | 1.02–1.07e | 1.05 | 1.02–1.07e | 1.05 | 1.02–1.07e |
| 2 | 3844 | 46,547.67 | 82.58 | 4.83 | 4.67–4.99f | 1.13 | 1.08–1.17f | 1.13 | 1.09–1.18f | 1.13 | 1.09–1.18f |
| ≥ 3 | 600 | 3724.94 | 161.08 | 9.42 | 8.69–10.22f | 1.25 | 1.15–1.36e | 1.25 | 1.15–1.36e | 1.25 | 1.15–1.36e |
| Every 1 component increase | 2.15 | 2.13–2.18f | 1.06 | 1.04–1.08f | 1.06 | 1.04–1.08f | 1.06 | 1.04–1.08f | |||
| Cardiovascular events | |||||||||||
| Number of frailty components | |||||||||||
| 0 | 28,054 | 1,465,567.99 | 19.14 | 1 | – | 1 | – | 1 | – | 1 | – |
| 1 | 13,358 | 338,756.78 | 39.43 | 2.05 | 2.01–2.1f | 1.05 | 1.02–1.07e | 1.05 | 1.03–1.08f | 1.05 | 1.03–1.08f |
| 2 | 3422 | 40,228.14 | 85.06 | 4.38 | 4.22–4.54f | 1.15 | 1.1–1.2f | 1.16 | 1.1–1.2f | 1.16 | 1.1–1.2f |
| ≥ 3 | 375 | 3083.18 | 121.63 | 6.18 | 5.58–6.85f | 1.13 | 1.01–1.25g | 1.13 | 1.02–1.25e | 1.13 | 1.02–1.25g |
| Every 1 component increase | 2.03 | 2–2.05f | 1.06 | 1.04–1.08f | 1.06 | 1.04–1.08f | 1.06 | 1.04–1.08f | |||
| Hospitalization | |||||||||||
| Number of frailty components | |||||||||||
| 0 | 144,963 | 1,180,101.25 | 122.84 | 1 | – | 1 | – | 1 | – | 1 | – |
| 1 | 49,391 | 249,466.94 | 197.77 | 1.58 | 1.57–1.6f | 1.06 | 1.05–1.07f | 1.06 | 1.05–1.07f | 1.06 | 1.05–1.07f |
| 2 | 9787 | 24,850.17 | 393.84 | 3.01 | 2.95–3.07f | 1.16 | 1.14–1.19f | 1.16 | 1.13–1.19f | 1.16 | 1.13–1.19f |
| ≥ 3 | 1040 | 1659.98 | 626.51 | 4.59 | 4.32–4.88f | 1.25 | 1.18–1.33f | 1.25 | 1.17–1.33f | 1.25 | 1.17–1.33f |
| Every 1 component increase | 1.65 | 1.64–1.67f | 1.07 | 1.06–1.08f | 1.07 | 1.06–1.08f | 1.07 | 1.06–1.08f | |||
| ICU admission | |||||||||||
| Number of frailty components | |||||||||||
| 0 | 31,913 | 1,470,810.05 | 21.7 | 1 | – | 1 | – | 1 | – | 1 | – |
| 1 | 14,758 | 342,678.79 | 43.07 | 1.98 | 1.94–2.02f | 1.05 | 1.03–1.07f | 1.05 | 1.02–1.07f | 1.05 | 1.03–1.07f |
| 2 | 3839 | 41,595.75 | 92.29 | 4.21 | 4.07–4.36f | 1.13 | 1.08–1.14f | 1.13 | 1.08–1.17f | 1.13 | 1.09-1.17f |
| ≥ 3 | 492 | 3140.36 | 156.67 | 7.07 | 6.47–7.73f | 1.17 | 1.06–1.28e | 1.16 | 1.06–1.27e | 1.16 | 1.06–1.27e |
| Every 1 component increase | 2 | 1.97–2.02f | 1.06 | 1.04–1.07f | 1.06 | 1.04–1.07f | 1.06 | 1.04–1.07f | |||
CI confidence interval, HR hazard ratio, ICU intensive care unit
aPer 1000 person-year
bAdjusted for demographic profiles, comorbidities, aDSCI, and medications
cAdjusted for demographic profiles, comorbidities (including obesity, mental illnesses, hypoglycemia history), substance use (smoking and alcohol abuse), aDCSI, and medications
dAnalysis including both type 1 and type 2 DM patients
ep < 0.01
fp < 0.001
gp < 0.05